ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
KalVista Pharmaceuticals Inc

KalVista Pharmaceuticals Inc (KALV)

7.85
-0.39
(-4.73%)
終了 1月12日 6:00AM
7.85
-0.01
(-0.13%)
取引時間後: 9:10AM

個人投資家向けのプロ仕様のツール。

主要統計と詳細

通貨
7.85
買値
7.50
売値
11.75
出来高
418,455
7.745 日の範囲 8.21
7.85 52 週間の範囲 16.88
時価総額
前日終値
8.24
始値
8.09
時刻
9
@
8.49
最終取引時間
財務取引量
US$ 3,319,873
VWAP
7.9336
平均取引量 (3 か月)
357,551
発行済株式数
49,417,986
配当利回り
-
PER
-3.07
1 株当たり利益 (EPS)
-2.56
歳入
-
純利益
-126.64M

KalVista Pharmaceuticals Inc について

KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angio... KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. 詳細を表示

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Dover, Delaware, USA
設立
-
KalVista Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker KALV. The last closing price for KalVista Pharmaceuticals was US$8.24. Over the last year, KalVista Pharmaceuticals shares have traded in a share price range of US$ 7.85 to US$ 16.88.

KalVista Pharmaceuticals currently has 49,417,986 shares in issue. The market capitalisation of KalVista Pharmaceuticals is US$407.20 million. KalVista Pharmaceuticals has a price to earnings ratio (PE ratio) of -3.07.

KALV 最新ニュース

KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) today announced that the compensation committee of KalVista’s board of directors granted nine newly-hired employees inducement options to purchase an...

KalVista Appoints Jeb Ledell as Chief Operating Officer

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that Jeb Ledell has joined the Company as Chief Operating Officer (COO). Mr. Ledell is an accomplished public company COO with a...

KalVista Pharmaceuticals Reports Second Fiscal Quarter Results and Provides Operational Update

–Continuing to build commercial infrastructure; on track for potential sebetralstat launch in Q2 2025– –Multinational regulatory submissions for sebetralstat position Company to transform...

KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the compensation committee of KalVista’s board of directors granted five newly-hired employees inducement options to purchase...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-1.095-12.24147568478.9459.15497.851738478.6573157CS
4-0.678-7.950281425898.5289.227.853690338.60138783CS
12-4.31-35.444078947412.1612.857.853575519.72015752CS
26-4.47-36.282467532512.3215.57.8536017511.16414448CS
52-4.76-37.747819191112.6116.887.8546584312.34679722CS
156-4.92-38.527799530112.7717.3454.1234694910.65499245CS
260-8.01-50.504413619215.86454.1231667815.67732677CS

KALV - Frequently Asked Questions (FAQ)

What is the current KalVista Pharmaceuticals share price?
The current share price of KalVista Pharmaceuticals is US$ 7.85
How many KalVista Pharmaceuticals shares are in issue?
KalVista Pharmaceuticals has 49,417,986 shares in issue
What is the market cap of KalVista Pharmaceuticals?
The market capitalisation of KalVista Pharmaceuticals is USD 407.2M
What is the 1 year trading range for KalVista Pharmaceuticals share price?
KalVista Pharmaceuticals has traded in the range of US$ 7.85 to US$ 16.88 during the past year
What is the PE ratio of KalVista Pharmaceuticals?
The price to earnings ratio of KalVista Pharmaceuticals is -3.07
What is the reporting currency for KalVista Pharmaceuticals?
KalVista Pharmaceuticals reports financial results in USD
What is the latest annual profit for KalVista Pharmaceuticals?
The latest annual profit of KalVista Pharmaceuticals is USD -126.64M
What is the registered address of KalVista Pharmaceuticals?
The registered address for KalVista Pharmaceuticals is 3500 S DUPONT HWY, DOVER, DELAWARE, 19901
What is the KalVista Pharmaceuticals website address?
The website address for KalVista Pharmaceuticals is www.kalvista.com
Which industry sector does KalVista Pharmaceuticals operate in?
KalVista Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
VRMEVerifyMe Inc
US$ 2.57
(52.98%)
57.83M
WKEYWISeKey International Holdings AG
US$ 10.041
(52.83%)
6.72M
DATSDatChat Inc
US$ 4.8105
(49.86%)
158.65M
CDTConduit Pharmaceuticals Inc
US$ 0.1214
(48.05%)
1.17B
INTZIntrusion Inc
US$ 2.8888
(44.44%)
40.61M
IGMSIGM Biosciences Inc
US$ 2.095
(-66.21%)
5.69M
CDTGCDT Environmental Technology Investment Holdings Ltd
US$ 1.87
(-51.30%)
2.28M
MODVModivCare Inc
US$ 6.51
(-47.88%)
2.73M
AIFUAIX Inc
US$ 0.420501
(-47.76%)
7.83M
MRSNMersana Therapeutics Inc
US$ 0.691
(-46.85%)
58.31M
CDTConduit Pharmaceuticals Inc
US$ 0.1214
(48.05%)
1.17B
NVDANVIDIA Corporation
US$ 135.91
(-3.00%)
207.53M
RGTIRigetti Computing Inc
US$ 8.9299
(-11.06%)
178.82M
VMARVision Marine Technologies Inc
US$ 2.14
(40.79%)
175.57M
DATSDatChat Inc
US$ 4.8105
(49.86%)
158.65M

KALV Discussion

投稿を表示